Results
Laurus Labs FY26 Revenue Up 23% with Strong CDMO Growth
Laurus Labs reported FY26 revenue of ₹6,813 crore, a 23% YoY increase driven by 36% growth in CDMO business and 18% growth in Affordable Medicines.
EBITDA surged 64% to ₹1,826 crore with margins expan
